Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Israel-based bhipharmaceutical firm HealOr has appointed Michael Sabolinski as the new CEO.
Subscribe to our email newsletter
HealOr is a developer of new treatments for acute and chronic wounds such as diabetic foot ulcer (DFU), psoriasis and others.
Most recently, Sabolinski has worked as the chief medical officer of the company.
Sabolinski said he look forward to working closely with the company’s supportive Board of Directors.
"Our main goal is to achieve FDA approval for HO/03/03, our flagship product for the treatment of diabetic foot ulcers, which is currently being studied in a Phase II/III clinical trial in the US and India," Sabolinski said.